Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Covidien, a healthcare products company, and PETNET Solutions, a wholly-owned subsidiary of Siemens Medical Solutions USA, and a distributor of radiopharmaceuticals, have entered into a co-marketing agreement to offer a combined portfolio of high energy and low energy radioisotopes to the nuclear medicine community in the US.
Subscribe to our email newsletter
Through the agreement, Covidien Imaging Solutions and PETNET will create a network of nuclear imaging product offerings to expand customer access to a wider range of products, including molecular imaging agents, or radiopharmaceuticals, designed to illuminate conditions, such as cancer or heart disease, during imaging procedures.
The agreement brings together Covidien’s single photo emission computed tomography (SPECT) products and PETNET’s positron emission tomography products. Additionally, this agreement allows both companies to offer customers enhanced service, expertise and product sourcing options.
Steve Hanley, president of imaging solutions at Covidien, said: “With the agreement we are positioned to offer our nuclear medicine customers expanded access to both product lines to help them provide better patient diagnostic services. It also provides PETNET with access to our extensive SPECT product offerings.”